Results 151 to 160 of about 9,215 (199)

Radioimmunotherapy

, 2004
openaire   +1 more source

DLL3-targeted immunoPET and radioimmunotherapy ligands. [PDF]

Am J Nucl Med Mol Imaging
Liang SH.
europepmc   +1 more source

Treatment of Follicular Lymphoma With CHOP and Anti-CD20 Therapy: 15-Year Follow-Up of the SWOG S0016 Trial.

JAMA Oncol
Shadman M, LeBlanc M, Rimsza L, Leonard JP, Smith SM, Li H, Friedberg JW.   +6 more
europepmc   +1 more source

Cancer Radioimmunotherapy [PDF]

Immunotherapy, 2011
Targeting of radionuclides with antibodies, or radioimmunotherapy, has been an active field of research spanning nearly 50 years, evolving with advancing technologies in molecular biology and chemistry, and with many important preclinical and clinical studies illustrating the benefits, but also the challenges, which all forms of targeted therapies face.
David M Goldenberg
exaly   +4 more sources

Clinical Radioimmunotherapy—The Role of Radiobiology

Nature Reviews Clinical Oncology, 2011
International audienceConventional external-beam radiation therapy is dedicated to the treatment of localized disease, whereas radioimmunotherapy represents an innovative tool for the treatment of local or diffuse tumors.
Jean-Pierre Pouget, André Pèlegrin, Manuel Bardies   +2 more
exaly   +2 more sources

Radioimmunotherapy of Pancreatic Ductal Adenocarcinoma: A Review of the Current Status of Literature [PDF]

Cancers, 2020
Pancreatic ductal adenocarcinoma (PDAC) has long been associated with low survival rates. A lack of accurate diagnostic tests and limited treatment options contribute to the poor prognosis of PDAC.
Eva Bezak, Ashleigh Hull
exaly   +2 more sources

Some of the next articles are maybe not open access.

Related searches:

Experimental radioimmunotherapy

Medical Physics, 1993
Radiolabeled monoclonal antibodies have been used for radioimmunotherapy studies with human tumor spheroids and murine and human tumor xenografts in experimental animals. This paper reviews the work that has been performed in these models with different types of cancer, and highlights those papers that have presented dosimetry estimates and attempts to
D J, Buchsbaum, V K, Langmuir, B W, Wessels   +2 more
openaire   +2 more sources

Radioimmunotherapy of Brain Tumor

Neurological Research, 2006
Despite years of intensive research, the prognosis of high-grade gliomas (HGG) remains poor, as these tumors are highly resistant to currently available therapies. Therefore, there is a need for the development of new therapeutic strategies, such as the use of monoclonal antibodies (MoAbs) in association with radioisotopes, in order to achieve better ...
Giovanni Paganelli, Mahila Ferrari, Mirco Bartolomei   +2 more
exaly   +3 more sources

An overview of radioimmunotherapy

Cancer Immunology Immunotherapy, 1991
In reviewing the current state of affairs in radioimmunotherapy the paper focuses on the main difficulties thus far encountered and the procedures designed to avoid or circumvent these problems. The long range beta-emitters 90Y and 188Re have replaced 131I as the isotopes currently receiving most attention for use in radioimmunotherapy, and a range of ...
A, Maraveyas, A A, Epenetos
openaire   +2 more sources

Radioimmunodetection and Radioimmunotherapy

Cancer Investigation, 1984
The development of monoclonal antibodies that recognize tumor-associated antigens has led to significantly greater practical possibilities for producing highly specific radiolabeled antibodies for diagnosis and therapy of human tumors. A number of problems remain before this technique will be ready for routine clinical application however.
S M, Larson, J A, Carrasquillo, J C, Reynolds   +2 more
openaire   +2 more sources